← k3vl4r
Log inGet started →

HAE (Haemonetics) Price Forecast

AI-generated price forecast for Haemonetics (HAE) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of September 2026: K3vl4r's AI model currently reads HAE as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 108.40. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

108.40

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

HAE forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~13 days out———
Daily~3 months out▼ Down-48.70%—
Weekly~1.8 years out▼ Down-27.71%—

Latest HAE news

From the market-news feed the forecasts are read against.

  • PAHC vs. HAE: Which Stock Should Value Investors Buy Now? · Yahoo · Sep 18
  • Citigroup Upgrades Haemonetics to Buy from Neutral · Fintel · Sep 17
  • HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today? · Yahoo · Sep 17
  • Citigroup Upgrades Haemonetics to Buy, Raises Price Target to $123 · Benzinga · Sep 17
  • Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics · Yahoo · Sep 15

🔒

See the full HAE forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

HAE forecast — frequently asked

Will HAE go up?

K3vl4r's AI model currently reads HAE as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the HAE price prediction for 2026?

K3vl4r's model projects HAE toward $107.87 over the next ~3 months, a -0.5% move from $108.40. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could HAE reach?

Over its longest horizon (~~1.8 years), the model's projected target for HAE is $106.21 (-0.3% vs $106.51). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

EELVHUMATFXCBUSEMBCSNDXCODXJBIOEOLSAVTXTVRDIMVTMGNXSENS

Will HAE reach…?

Will HAE reach $200.00?Will HAE reach $250.00?Will HAE reach $500.00?

Or see the full HAE price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare HAE

HAE vs EELVHAE vs HUMAHAE vs TFXHAE vs CBUSHAE vs EMBCHAE vs SNDX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.